ROVI updates its strategy in a meeting with shareholders, investors and analysts.
Lun, 25/11/2019 - 11:15
0 minROVI updates its strategy in a meeting with shareholders, investors and analysts.
Relacionados
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) ha anunciado la compra de Falithrom®, propiedad de Hexal AG (“Hexal”), una compañía de la...
1 min
09/01/2019
0185.jpg